Arixtra

This page contains recent news articles, when available, and an overview of Arixtra but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.


Overview:

Arixtra
(when available)

Pharmacology and use:
Fondaparinux is a synthetic and specific inhibitor of activated Factor X (Xa) indicated for the prophylaxis of deep vein thrombosis, which may lead to pulmonary embolism. Fondaparinux is also indicated for the treatment of acute deep vein thrombosis when administered in conjunction with warfarin, and the treatment of acute pulmonary embolism when administered in conjunction with warfarin. Fondaparinux does not inactivate thrombin (activated Factor II) and has no known effect on platelet function. At the recommended dose, Fondaparinux does not affect fibrinolytic activity or bleeding time. For the treatment of prophylaxis of deep vein thrombosis.

Mechanism Of Action:
The antithrombotic activity of Fondaparinux is the result of antithrombin III (ATIII)-mediated selective inhibition of Factor Xa. By selectively binding to ATIII, Fondaparinux potentiates (about 300 times) the innate neutralization of Factor Xa by ATIII. Neutralization of Factor Xa interrupts the blood coagulation cascade and thus inhibits thrombin formation and thrombus development.

News Articles on Fondaparinux

GlaxoSmithKline Pharmaceutical 3Q Net Up 6.8% At INR1.41B  -  ‎Oct 30, 2009‎
GlaxoSmithKline Pharmaceuticals has launched drugs such as cervical cancer vaccine Cervarix, antithrombotic agent Arixtra, rotavirus diarrhea vaccine ... Wall Street Journal

<ACL.AX> - ALCHEMIA LIMITED  -  ‎Nov 10, 2009‎
The broker notes FDA approval for the company's generic version of Arixtra is expected before Christmas, but exact timing remains uncertain. ... Ninemsn

Pharma outlook: What's brewing at DRL, Lupin, Pfizer?  -  ‎Oct 23, 2009‎
Fondapariniux is something that people are awaiting because they had the approval and Arixtra as the brand is called is a very strong product. ... Moneycontrol.com

Jusqu'à quel âge prescrire une statine ou un AVK ?  -  ‎Oct 19, 2009‎
...nous disposerons des nouveaux anticoagulants oraux que l'on a faite avec la nouvelle génération d'anticoagulants parentéraux (HBPM versus Arixtra), c. ... theheart.org/fr

Brand Names/Synonyms:
Arixtra is also known by the following brand names and/or synonymsArixtra; Fondaparinux sodium

Drug Category:
Arixtra is categorized under the following by the FDA: Anticoagulants; Antithrombotics; ATC:B01AX05

Dosage Forms:
Solution

Absorption:
100%

Interactions:
[an error occurred while processing this directive]



Chemical IUPAC Name:
decasodium 6-[6-[2-carboxylato-4-hydroxy-6-[4-hydroxy-6-methoxy-5-sulfonatoamino-2-(sulfonatooxymethyl)oxan-3-yl]oxy-5-sulfonatooxy-oxan-3-yl]oxy-5-sulfonatoamino-4-sulfonatooxy-2-(sulfonatooxymethyl)oxan-3-yl]oxy-3-[4,5-dihydroxy-3-sulfonatoamino-6-(sulfonatooxymethyl)oxan-2-yl]oxy-4,5-dihydroxy-oxane-2-carboxylate





Health Home | Conditions | Cancer | Medications | Surgery | Vaccines


The Cancer News Network


Disclaimer:

Contact a physician with regard to health concerns. Email requests for further health information will be discarded.

The materials contained on this Web site are for informational purposes only and do not constitute health or medical advice. Use of information on this site does not create or constitute any kind of agreement or contract between you and the owners or users of this site, the owners of the servers upon which it is housed, or anyone else who is in any way connected with this site.

Many links on cancernewsnetwork.org lead to other sites. cancernewsnetwork.org does not sponsor, endorse or otherwise approve of the materials appearing in such sites. Nor is CancerNewsNetwork.org responsible for dead or misdirected links.

IF YOU NEED A LINK OR TEXT REMOVED FROM THIS PAGE PLEASE CONTACT cancernewsnetwork (at) live.com.
We will do our best to accommodate your request.



COPYRIGHT 2009 CANCERNEWSNETWORK | Privacy